This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Isaac George, CTSNet Board Member and Co-Director of the Structural Heart and Valve Center, Surgical Director of Structural Heart Disease, and Co-Director of the Mitral and Tricuspid Center at Columbia University Medical Center/NewYork-Presbyterian, NY, USA, about the lifetime management of aortic valve disease.
Chapters
00:00 Intro
02:11 AATS-CTSN Randomized Trials
04:37 JANS 1, Consensus Statement ALAD
10:28 JANS 2, Lung Re-Transplantation Outcomes
12:19 JANS 3, Aortic Homografts, EURECAH
15:15 JANS 4, Lobectomy Cost Analysis
18:10 Video 1, Anomalous L Coronary Artery
19:38 Video 2, Pulm Valve Replacement Reop
21:38 Video 3, Giant Pulm Artery Aneurysm
23:28 Dr. George Discussion
33:18 Upcoming Events
34:05 Closing
They explored the expansion of transcatheter aortic valve replacement (TAVR), emphasizing the crucial role of the heart valve team in this process. The discussion highlighted the necessity for surgeons to be actively involved in the decision-making process surrounding TAVR, particularly in the early stages. They also addressed the importance of lifetime management of the valve, selecting the appropriate valve, and valve durability. Additionally, they discussed the significance of providing patients with multiple surgical options, the Ross procedure, mechanical valves, and explored which procedures patients are choosing.
Joel also highlights recent JANS articles on the ISHLT consensus statement on acute lung allograft dysfunction, aortic homografts for native and prosthetic aortic valve and root endocarditis, how outcomes after lung re-transplantation for restrictive allograft syndrome have not improved over two decades, and the financial burden of postoperative adverse events following lobectomy.
In addition, Joel explores the surgical repair of an anomalous left coronary artery from the right pulmonary artery, minimally invasive pulmonary valve replacement in reoperative settings, and surgical management of giant pulmonary artery aneurysm using a T-shaped graft-valve strategy.
Before closing, Joel highlights upcoming events in CT surgery.
JANS Items Mentioned
ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities
Aortic Homografts for Native and Prosthetic Aortic Valve and Root Endocarditis: Results From the EUropean REgistry of Cryopreserved Aortic Homografts EURECAH
Outcomes After Lung Re-Transplantation for Restrictive Allograft Syndrome Have Not Improved Over Two Decades
Financial Burden of Postoperative Adverse Events Following Lobectomy: Cost Analysis From 10 High-Volume Canadian Hospitals
CTSNet Content Mentioned
Surgical Repair of an Anomalous Left Coronary Artery From the Right Pulmonary Artery
Minimally Invasive Pulmonary Valve Replacement in Reoperative Settings
Surgical Management of Giant Pulmonary Artery Aneurysm Using a T-Shaped Graft-Valve Strategy
Other Items Mentioned
CTSNet Innovation Video Competition
Career Center
CTSNet Events
Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.